COVID-19 Impact on Global Biopharmaceutical Buffers Market Insights, Forecast to 2026
Biopharmaceutical Buffers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Buffers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biopharmaceutical Buffers market is segmented into
The Biopharmaceutical Buffers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biopharmaceutical Buffers market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Biopharmaceutical Buffers Market Share Analysis
Biopharmaceutical Buffers market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Biopharmaceutical Buffers by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Biopharmaceutical Buffers business, the date to enter into the Biopharmaceutical Buffers market, Biopharmaceutical Buffers product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Biopharmaceutical Buffers market is segmented into
- Sterile Buffer
- Non-sterile Buffer
- Recombinant Proteins
- Monoclonal Antibodies
- Antibiotics
- Probiotics
- Other
The Biopharmaceutical Buffers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biopharmaceutical Buffers market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Biopharmaceutical Buffers Market Share Analysis
Biopharmaceutical Buffers market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Biopharmaceutical Buffers by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Biopharmaceutical Buffers business, the date to enter into the Biopharmaceutical Buffers market, Biopharmaceutical Buffers product introduction, recent developments, etc.
The major vendors covered:
- GE Healthcare
- Thermo Fisher Scientific
- Danaher Corporation
- Sartorius StedimBiotech
- Merck
- Eppendorf
- Roche
- Nova Biomedicals
- Lonza
- Becton, and Dickinson and Company
1 STUDY COVERAGE
1.1 Biopharmaceutical Buffers Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Biopharmaceutical Buffers Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Type
1.4.2 Sterile Buffer
1.4.3 Non-sterile Buffer
1.5 Market by Application
1.5.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Application
1.5.2 Recombinant Proteins
1.5.3 Monoclonal Antibodies
1.5.4 Antibiotics
1.5.5 Probiotics
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Buffers Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Buffers Industry
1.6.1.1 Biopharmaceutical Buffers Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical Buffers Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical Buffers Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biopharmaceutical Buffers Market Size Estimates and Forecasts
2.1.1 Global Biopharmaceutical Buffers Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Biopharmaceutical Buffers Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Biopharmaceutical Buffers Production Estimates and Forecasts 2015-2026
2.2 Global Biopharmaceutical Buffers Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Biopharmaceutical Buffers Manufacturers Geographical Distribution
2.4 Key Trends for Biopharmaceutical Buffers Markets & Products
2.5 Primary Interviews with Key Biopharmaceutical Buffers Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Biopharmaceutical Buffers Manufacturers by Production Capacity
3.1.1 Global Top Biopharmaceutical Buffers Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Biopharmaceutical Buffers Manufacturers by Production (2015-2020)
3.1.3 Global Top Biopharmaceutical Buffers Manufacturers Market Share by Production
3.2 Global Top Biopharmaceutical Buffers Manufacturers by Revenue
3.2.1 Global Top Biopharmaceutical Buffers Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Biopharmaceutical Buffers Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Biopharmaceutical Buffers Revenue in 2019
3.3 Global Biopharmaceutical Buffers Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 BIOPHARMACEUTICAL BUFFERS PRODUCTION BY REGIONS
4.1 Global Biopharmaceutical Buffers Historic Market Facts & Figures by Regions
4.1.1 Global Top Biopharmaceutical Buffers Regions by Production (2015-2020)
4.1.2 Global Top Biopharmaceutical Buffers Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Biopharmaceutical Buffers Production (2015-2020)
4.2.2 North America Biopharmaceutical Buffers Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Biopharmaceutical Buffers Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Biopharmaceutical Buffers Production (2015-2020)
4.3.2 Europe Biopharmaceutical Buffers Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Biopharmaceutical Buffers Import & Export (2015-2020)
4.4 China
4.4.1 China Biopharmaceutical Buffers Production (2015-2020)
4.4.2 China Biopharmaceutical Buffers Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Biopharmaceutical Buffers Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Biopharmaceutical Buffers Production (2015-2020)
4.5.2 Japan Biopharmaceutical Buffers Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Biopharmaceutical Buffers Import & Export (2015-2020)
5 BIOPHARMACEUTICAL BUFFERS CONSUMPTION BY REGION
5.1 Global Top Biopharmaceutical Buffers Regions by Consumption
5.1.1 Global Top Biopharmaceutical Buffers Regions by Consumption (2015-2020)
5.1.2 Global Top Biopharmaceutical Buffers Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Biopharmaceutical Buffers Consumption by Application
5.2.2 North America Biopharmaceutical Buffers Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Biopharmaceutical Buffers Consumption by Application
5.3.2 Europe Biopharmaceutical Buffers Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Buffers Consumption by Application
5.4.2 Asia Pacific Biopharmaceutical Buffers Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Biopharmaceutical Buffers Consumption by Application
5.5.2 Central & South America Biopharmaceutical Buffers Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Biopharmaceutical Buffers Consumption by Application
5.6.2 Middle East and Africa Biopharmaceutical Buffers Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Biopharmaceutical Buffers Market Size by Type (2015-2020)
6.1.1 Global Biopharmaceutical Buffers Production by Type (2015-2020)
6.1.2 Global Biopharmaceutical Buffers Revenue by Type (2015-2020)
6.1.3 Biopharmaceutical Buffers Price by Type (2015-2020)
6.2 Global Biopharmaceutical Buffers Market Forecast by Type (2021-2026)
6.2.1 Global Biopharmaceutical Buffers Production Forecast by Type (2021-2026)
6.2.2 Global Biopharmaceutical Buffers Revenue Forecast by Type (2021-2026)
6.2.3 Global Biopharmaceutical Buffers Price Forecast by Type (2021-2026)
6.3 Global Biopharmaceutical Buffers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Biopharmaceutical Buffers Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Biopharmaceutical Buffers Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 GE Healthcare
8.1.1 GE Healthcare Corporation Information
8.1.2 GE Healthcare Overview and Its Total Revenue
8.1.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 GE Healthcare Product Description
8.1.5 GE Healthcare Recent Development
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Corporation Information
8.2.2 Thermo Fisher Scientific Overview and Its Total Revenue
8.2.3 Thermo Fisher Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Thermo Fisher Scientific Product Description
8.2.5 Thermo Fisher Scientific Recent Development
8.3 Danaher Corporation
8.3.1 Danaher Corporation Corporation Information
8.3.2 Danaher Corporation Overview and Its Total Revenue
8.3.3 Danaher Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Danaher Corporation Product Description
8.3.5 Danaher Corporation Recent Development
8.4 Sartorius StedimBiotech
8.4.1 Sartorius StedimBiotech Corporation Information
8.4.2 Sartorius StedimBiotech Overview and Its Total Revenue
8.4.3 Sartorius StedimBiotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Sartorius StedimBiotech Product Description
8.4.5 Sartorius StedimBiotech Recent Development
8.5 Merck
8.5.1 Merck Corporation Information
8.5.2 Merck Overview and Its Total Revenue
8.5.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Merck Product Description
8.5.5 Merck Recent Development
8.6 Eppendorf
8.6.1 Eppendorf Corporation Information
8.6.2 Eppendorf Overview and Its Total Revenue
8.6.3 Eppendorf Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Eppendorf Product Description
8.6.5 Eppendorf Recent Development
8.7 Roche
8.7.1 Roche Corporation Information
8.7.2 Roche Overview and Its Total Revenue
8.7.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Roche Product Description
8.7.5 Roche Recent Development
8.8 Nova Biomedicals
8.8.1 Nova Biomedicals Corporation Information
8.8.2 Nova Biomedicals Overview and Its Total Revenue
8.8.3 Nova Biomedicals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Nova Biomedicals Product Description
8.8.5 Nova Biomedicals Recent Development
8.9 Lonza
8.9.1 Lonza Corporation Information
8.9.2 Lonza Overview and Its Total Revenue
8.9.3 Lonza Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Lonza Product Description
8.9.5 Lonza Recent Development
8.10 Becton, and Dickinson and Company
8.10.1 Becton, and Dickinson and Company Corporation Information
8.10.2 Becton, and Dickinson and Company Overview and Its Total Revenue
8.10.3 Becton, and Dickinson and Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Becton, and Dickinson and Company Product Description
8.10.5 Becton, and Dickinson and Company Recent Development
8.11 GEA
8.11.1 GEA Corporation Information
8.11.2 GEA Overview and Its Total Revenue
8.11.3 GEA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 GEA Product Description
8.11.5 GEA Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Biopharmaceutical Buffers Regions Forecast by Revenue (2021-2026)
9.2 Global Top Biopharmaceutical Buffers Regions Forecast by Production (2021-2026)
9.3 Key Biopharmaceutical Buffers Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 BIOPHARMACEUTICAL BUFFERS CONSUMPTION FORECAST BY REGION
10.1 Global Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.2 North America Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.3 Europe Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.5 Latin America Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biopharmaceutical Buffers Sales Channels
11.2.2 Biopharmaceutical Buffers Distributors
11.3 Biopharmaceutical Buffers Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL BIOPHARMACEUTICAL BUFFERS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Biopharmaceutical Buffers Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Biopharmaceutical Buffers Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Type
1.4.2 Sterile Buffer
1.4.3 Non-sterile Buffer
1.5 Market by Application
1.5.1 Global Biopharmaceutical Buffers Market Size Growth Rate by Application
1.5.2 Recombinant Proteins
1.5.3 Monoclonal Antibodies
1.5.4 Antibiotics
1.5.5 Probiotics
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Buffers Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Buffers Industry
1.6.1.1 Biopharmaceutical Buffers Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical Buffers Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical Buffers Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biopharmaceutical Buffers Market Size Estimates and Forecasts
2.1.1 Global Biopharmaceutical Buffers Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Biopharmaceutical Buffers Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Biopharmaceutical Buffers Production Estimates and Forecasts 2015-2026
2.2 Global Biopharmaceutical Buffers Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Biopharmaceutical Buffers Manufacturers Geographical Distribution
2.4 Key Trends for Biopharmaceutical Buffers Markets & Products
2.5 Primary Interviews with Key Biopharmaceutical Buffers Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Biopharmaceutical Buffers Manufacturers by Production Capacity
3.1.1 Global Top Biopharmaceutical Buffers Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Biopharmaceutical Buffers Manufacturers by Production (2015-2020)
3.1.3 Global Top Biopharmaceutical Buffers Manufacturers Market Share by Production
3.2 Global Top Biopharmaceutical Buffers Manufacturers by Revenue
3.2.1 Global Top Biopharmaceutical Buffers Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Biopharmaceutical Buffers Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Biopharmaceutical Buffers Revenue in 2019
3.3 Global Biopharmaceutical Buffers Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 BIOPHARMACEUTICAL BUFFERS PRODUCTION BY REGIONS
4.1 Global Biopharmaceutical Buffers Historic Market Facts & Figures by Regions
4.1.1 Global Top Biopharmaceutical Buffers Regions by Production (2015-2020)
4.1.2 Global Top Biopharmaceutical Buffers Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Biopharmaceutical Buffers Production (2015-2020)
4.2.2 North America Biopharmaceutical Buffers Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Biopharmaceutical Buffers Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Biopharmaceutical Buffers Production (2015-2020)
4.3.2 Europe Biopharmaceutical Buffers Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Biopharmaceutical Buffers Import & Export (2015-2020)
4.4 China
4.4.1 China Biopharmaceutical Buffers Production (2015-2020)
4.4.2 China Biopharmaceutical Buffers Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Biopharmaceutical Buffers Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Biopharmaceutical Buffers Production (2015-2020)
4.5.2 Japan Biopharmaceutical Buffers Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Biopharmaceutical Buffers Import & Export (2015-2020)
5 BIOPHARMACEUTICAL BUFFERS CONSUMPTION BY REGION
5.1 Global Top Biopharmaceutical Buffers Regions by Consumption
5.1.1 Global Top Biopharmaceutical Buffers Regions by Consumption (2015-2020)
5.1.2 Global Top Biopharmaceutical Buffers Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Biopharmaceutical Buffers Consumption by Application
5.2.2 North America Biopharmaceutical Buffers Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Biopharmaceutical Buffers Consumption by Application
5.3.2 Europe Biopharmaceutical Buffers Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Buffers Consumption by Application
5.4.2 Asia Pacific Biopharmaceutical Buffers Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Biopharmaceutical Buffers Consumption by Application
5.5.2 Central & South America Biopharmaceutical Buffers Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Biopharmaceutical Buffers Consumption by Application
5.6.2 Middle East and Africa Biopharmaceutical Buffers Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Biopharmaceutical Buffers Market Size by Type (2015-2020)
6.1.1 Global Biopharmaceutical Buffers Production by Type (2015-2020)
6.1.2 Global Biopharmaceutical Buffers Revenue by Type (2015-2020)
6.1.3 Biopharmaceutical Buffers Price by Type (2015-2020)
6.2 Global Biopharmaceutical Buffers Market Forecast by Type (2021-2026)
6.2.1 Global Biopharmaceutical Buffers Production Forecast by Type (2021-2026)
6.2.2 Global Biopharmaceutical Buffers Revenue Forecast by Type (2021-2026)
6.2.3 Global Biopharmaceutical Buffers Price Forecast by Type (2021-2026)
6.3 Global Biopharmaceutical Buffers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Biopharmaceutical Buffers Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Biopharmaceutical Buffers Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 GE Healthcare
8.1.1 GE Healthcare Corporation Information
8.1.2 GE Healthcare Overview and Its Total Revenue
8.1.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 GE Healthcare Product Description
8.1.5 GE Healthcare Recent Development
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Corporation Information
8.2.2 Thermo Fisher Scientific Overview and Its Total Revenue
8.2.3 Thermo Fisher Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Thermo Fisher Scientific Product Description
8.2.5 Thermo Fisher Scientific Recent Development
8.3 Danaher Corporation
8.3.1 Danaher Corporation Corporation Information
8.3.2 Danaher Corporation Overview and Its Total Revenue
8.3.3 Danaher Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Danaher Corporation Product Description
8.3.5 Danaher Corporation Recent Development
8.4 Sartorius StedimBiotech
8.4.1 Sartorius StedimBiotech Corporation Information
8.4.2 Sartorius StedimBiotech Overview and Its Total Revenue
8.4.3 Sartorius StedimBiotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Sartorius StedimBiotech Product Description
8.4.5 Sartorius StedimBiotech Recent Development
8.5 Merck
8.5.1 Merck Corporation Information
8.5.2 Merck Overview and Its Total Revenue
8.5.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Merck Product Description
8.5.5 Merck Recent Development
8.6 Eppendorf
8.6.1 Eppendorf Corporation Information
8.6.2 Eppendorf Overview and Its Total Revenue
8.6.3 Eppendorf Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Eppendorf Product Description
8.6.5 Eppendorf Recent Development
8.7 Roche
8.7.1 Roche Corporation Information
8.7.2 Roche Overview and Its Total Revenue
8.7.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Roche Product Description
8.7.5 Roche Recent Development
8.8 Nova Biomedicals
8.8.1 Nova Biomedicals Corporation Information
8.8.2 Nova Biomedicals Overview and Its Total Revenue
8.8.3 Nova Biomedicals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Nova Biomedicals Product Description
8.8.5 Nova Biomedicals Recent Development
8.9 Lonza
8.9.1 Lonza Corporation Information
8.9.2 Lonza Overview and Its Total Revenue
8.9.3 Lonza Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Lonza Product Description
8.9.5 Lonza Recent Development
8.10 Becton, and Dickinson and Company
8.10.1 Becton, and Dickinson and Company Corporation Information
8.10.2 Becton, and Dickinson and Company Overview and Its Total Revenue
8.10.3 Becton, and Dickinson and Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Becton, and Dickinson and Company Product Description
8.10.5 Becton, and Dickinson and Company Recent Development
8.11 GEA
8.11.1 GEA Corporation Information
8.11.2 GEA Overview and Its Total Revenue
8.11.3 GEA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 GEA Product Description
8.11.5 GEA Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Biopharmaceutical Buffers Regions Forecast by Revenue (2021-2026)
9.2 Global Top Biopharmaceutical Buffers Regions Forecast by Production (2021-2026)
9.3 Key Biopharmaceutical Buffers Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 BIOPHARMACEUTICAL BUFFERS CONSUMPTION FORECAST BY REGION
10.1 Global Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.2 North America Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.3 Europe Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.5 Latin America Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Biopharmaceutical Buffers Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biopharmaceutical Buffers Sales Channels
11.2.2 Biopharmaceutical Buffers Distributors
11.3 Biopharmaceutical Buffers Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL BIOPHARMACEUTICAL BUFFERS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Biopharmaceutical Buffers Key Market Segments in This Study
Table 2. Ranking of Global Top Biopharmaceutical Buffers Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopharmaceutical Buffers Market Size Growth Rate by Type 2020-2026 (K MT) (Million US$)
Table 4. Major Manufacturers of Sterile Buffer
Table 5. Major Manufacturers of Non-sterile Buffer
Table 6. COVID-19 Impact Global Market: (Four Biopharmaceutical Buffers Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Biopharmaceutical Buffers Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Biopharmaceutical Buffers Players to Combat Covid-19 Impact
Table 11. Global Biopharmaceutical Buffers Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Biopharmaceutical Buffers Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharmaceutical Buffers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Buffers as of 2019)
Table 15. Biopharmaceutical Buffers Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Biopharmaceutical Buffers Product Offered
Table 17. Date of Manufacturers Enter into Biopharmaceutical Buffers Market
Table 18. Key Trends for Biopharmaceutical Buffers Markets & Products
Table 19. Main Points Interviewed from Key Biopharmaceutical Buffers Players
Table 20. Global Biopharmaceutical Buffers Production Capacity by Manufacturers (2015-2020) (K MT)
Table 21. Global Biopharmaceutical Buffers Production Share by Manufacturers (2015-2020)
Table 22. Biopharmaceutical Buffers Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Biopharmaceutical Buffers Revenue Share by Manufacturers (2015-2020)
Table 24. Biopharmaceutical Buffers Price by Manufacturers 2015-2020 (USD/MT)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biopharmaceutical Buffers Production by Regions (2015-2020) (K MT)
Table 27. Global Biopharmaceutical Buffers Production Market Share by Regions (2015-2020)
Table 28. Global Biopharmaceutical Buffers Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Biopharmaceutical Buffers Revenue Market Share by Regions (2015-2020)
Table 30. Key Biopharmaceutical Buffers Players in North America
Table 31. Import & Export of Biopharmaceutical Buffers in North America (K MT)
Table 32. Key Biopharmaceutical Buffers Players in Europe
Table 33. Import & Export of Biopharmaceutical Buffers in Europe (K MT)
Table 34. Key Biopharmaceutical Buffers Players in China
Table 35. Import & Export of Biopharmaceutical Buffers in China (K MT)
Table 36. Key Biopharmaceutical Buffers Players in Japan
Table 37. Import & Export of Biopharmaceutical Buffers in Japan (K MT)
Table 38. Global Biopharmaceutical Buffers Consumption by Regions (2015-2020) (K MT)
Table 39. Global Biopharmaceutical Buffers Consumption Market Share by Regions (2015-2020)
Table 40. North America Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 41. North America Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 42. Europe Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 43. Europe Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 44. Asia Pacific Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 45. Asia Pacific Biopharmaceutical Buffers Consumption Market Share by Application (2015-2020) (K MT)
Table 46. Asia Pacific Biopharmaceutical Buffers Consumption by Regions (2015-2020) (K MT)
Table 47. Latin America Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 48. Latin America Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 49. Middle East and Africa Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 50. Middle East and Africa Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 51. Global Biopharmaceutical Buffers Production by Type (2015-2020) (K MT)
Table 52. Global Biopharmaceutical Buffers Production Share by Type (2015-2020)
Table 53. Global Biopharmaceutical Buffers Revenue by Type (2015-2020) (Million US$)
Table 54. Global Biopharmaceutical Buffers Revenue Share by Type (2015-2020)
Table 55. Biopharmaceutical Buffers Price by Type 2015-2020 (USD/MT)
Table 56. Global Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 57. Global Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 58. Global Biopharmaceutical Buffers Consumption Share by Application (2015-2020)
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Major Businesses
Table 61. GE Healthcare Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 62. GE Healthcare Product
Table 63. GE Healthcare Recent Development
Table 64. Thermo Fisher Scientific Corporation Information
Table 65. Thermo Fisher Scientific Description and Major Businesses
Table 66. Thermo Fisher Scientific Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 67. Thermo Fisher Scientific Product
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Danaher Corporation Corporation Information
Table 70. Danaher Corporation Description and Major Businesses
Table 71. Danaher Corporation Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Danaher Corporation Product
Table 73. Danaher Corporation Recent Development
Table 74. Sartorius StedimBiotech Corporation Information
Table 75. Sartorius StedimBiotech Description and Major Businesses
Table 76. Sartorius StedimBiotech Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sartorius StedimBiotech Product
Table 78. Sartorius StedimBiotech Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Eppendorf Corporation Information
Table 85. Eppendorf Description and Major Businesses
Table 86. Eppendorf Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Eppendorf Product
Table 88. Eppendorf Recent Development
Table 89. Roche Corporation Information
Table 90. Roche Description and Major Businesses
Table 91. Roche Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Roche Product
Table 93. Roche Recent Development
Table 94. Nova Biomedicals Corporation Information
Table 95. Nova Biomedicals Description and Major Businesses
Table 96. Nova Biomedicals Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Nova Biomedicals Product
Table 98. Nova Biomedicals Recent Development
Table 99. Lonza Corporation Information
Table 100. Lonza Description and Major Businesses
Table 101. Lonza Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Lonza Product
Table 103. Lonza Recent Development
Table 104. Becton, and Dickinson and Company Corporation Information
Table 105. Becton, and Dickinson and Company Description and Major Businesses
Table 106. Becton, and Dickinson and Company Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Becton, and Dickinson and Company Product
Table 108. Becton, and Dickinson and Company Recent Development
Table 109. GEA Corporation Information
Table 110. GEA Description and Major Businesses
Table 111. GEA Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GEA Product
Table 113. GEA Recent Development
Table 114. Global Biopharmaceutical Buffers Revenue Forecast by Region (2021-2026) (Million US$)
Table 115. Global Biopharmaceutical Buffers Production Forecast by Regions (2021-2026) (K MT)
Table 116. Global Biopharmaceutical Buffers Production Forecast by Type (2021-2026) (K MT)
Table 117. Global Biopharmaceutical Buffers Revenue Forecast by Type (2021-2026) (Million US$)
Table 118. North America Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 119. Europe Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 120. Asia Pacific Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 121. Latin America Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 122. Middle East and Africa Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 123. Biopharmaceutical Buffers Distributors List
Table 124. Biopharmaceutical Buffers Customers List
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 1. Biopharmaceutical Buffers Key Market Segments in This Study
Table 2. Ranking of Global Top Biopharmaceutical Buffers Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopharmaceutical Buffers Market Size Growth Rate by Type 2020-2026 (K MT) (Million US$)
Table 4. Major Manufacturers of Sterile Buffer
Table 5. Major Manufacturers of Non-sterile Buffer
Table 6. COVID-19 Impact Global Market: (Four Biopharmaceutical Buffers Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Biopharmaceutical Buffers Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Biopharmaceutical Buffers Players to Combat Covid-19 Impact
Table 11. Global Biopharmaceutical Buffers Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Biopharmaceutical Buffers Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharmaceutical Buffers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Buffers as of 2019)
Table 15. Biopharmaceutical Buffers Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Biopharmaceutical Buffers Product Offered
Table 17. Date of Manufacturers Enter into Biopharmaceutical Buffers Market
Table 18. Key Trends for Biopharmaceutical Buffers Markets & Products
Table 19. Main Points Interviewed from Key Biopharmaceutical Buffers Players
Table 20. Global Biopharmaceutical Buffers Production Capacity by Manufacturers (2015-2020) (K MT)
Table 21. Global Biopharmaceutical Buffers Production Share by Manufacturers (2015-2020)
Table 22. Biopharmaceutical Buffers Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Biopharmaceutical Buffers Revenue Share by Manufacturers (2015-2020)
Table 24. Biopharmaceutical Buffers Price by Manufacturers 2015-2020 (USD/MT)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biopharmaceutical Buffers Production by Regions (2015-2020) (K MT)
Table 27. Global Biopharmaceutical Buffers Production Market Share by Regions (2015-2020)
Table 28. Global Biopharmaceutical Buffers Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Biopharmaceutical Buffers Revenue Market Share by Regions (2015-2020)
Table 30. Key Biopharmaceutical Buffers Players in North America
Table 31. Import & Export of Biopharmaceutical Buffers in North America (K MT)
Table 32. Key Biopharmaceutical Buffers Players in Europe
Table 33. Import & Export of Biopharmaceutical Buffers in Europe (K MT)
Table 34. Key Biopharmaceutical Buffers Players in China
Table 35. Import & Export of Biopharmaceutical Buffers in China (K MT)
Table 36. Key Biopharmaceutical Buffers Players in Japan
Table 37. Import & Export of Biopharmaceutical Buffers in Japan (K MT)
Table 38. Global Biopharmaceutical Buffers Consumption by Regions (2015-2020) (K MT)
Table 39. Global Biopharmaceutical Buffers Consumption Market Share by Regions (2015-2020)
Table 40. North America Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 41. North America Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 42. Europe Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 43. Europe Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 44. Asia Pacific Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 45. Asia Pacific Biopharmaceutical Buffers Consumption Market Share by Application (2015-2020) (K MT)
Table 46. Asia Pacific Biopharmaceutical Buffers Consumption by Regions (2015-2020) (K MT)
Table 47. Latin America Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 48. Latin America Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 49. Middle East and Africa Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 50. Middle East and Africa Biopharmaceutical Buffers Consumption by Countries (2015-2020) (K MT)
Table 51. Global Biopharmaceutical Buffers Production by Type (2015-2020) (K MT)
Table 52. Global Biopharmaceutical Buffers Production Share by Type (2015-2020)
Table 53. Global Biopharmaceutical Buffers Revenue by Type (2015-2020) (Million US$)
Table 54. Global Biopharmaceutical Buffers Revenue Share by Type (2015-2020)
Table 55. Biopharmaceutical Buffers Price by Type 2015-2020 (USD/MT)
Table 56. Global Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 57. Global Biopharmaceutical Buffers Consumption by Application (2015-2020) (K MT)
Table 58. Global Biopharmaceutical Buffers Consumption Share by Application (2015-2020)
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Major Businesses
Table 61. GE Healthcare Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 62. GE Healthcare Product
Table 63. GE Healthcare Recent Development
Table 64. Thermo Fisher Scientific Corporation Information
Table 65. Thermo Fisher Scientific Description and Major Businesses
Table 66. Thermo Fisher Scientific Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 67. Thermo Fisher Scientific Product
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Danaher Corporation Corporation Information
Table 70. Danaher Corporation Description and Major Businesses
Table 71. Danaher Corporation Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Danaher Corporation Product
Table 73. Danaher Corporation Recent Development
Table 74. Sartorius StedimBiotech Corporation Information
Table 75. Sartorius StedimBiotech Description and Major Businesses
Table 76. Sartorius StedimBiotech Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sartorius StedimBiotech Product
Table 78. Sartorius StedimBiotech Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Eppendorf Corporation Information
Table 85. Eppendorf Description and Major Businesses
Table 86. Eppendorf Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Eppendorf Product
Table 88. Eppendorf Recent Development
Table 89. Roche Corporation Information
Table 90. Roche Description and Major Businesses
Table 91. Roche Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Roche Product
Table 93. Roche Recent Development
Table 94. Nova Biomedicals Corporation Information
Table 95. Nova Biomedicals Description and Major Businesses
Table 96. Nova Biomedicals Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Nova Biomedicals Product
Table 98. Nova Biomedicals Recent Development
Table 99. Lonza Corporation Information
Table 100. Lonza Description and Major Businesses
Table 101. Lonza Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Lonza Product
Table 103. Lonza Recent Development
Table 104. Becton, and Dickinson and Company Corporation Information
Table 105. Becton, and Dickinson and Company Description and Major Businesses
Table 106. Becton, and Dickinson and Company Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Becton, and Dickinson and Company Product
Table 108. Becton, and Dickinson and Company Recent Development
Table 109. GEA Corporation Information
Table 110. GEA Description and Major Businesses
Table 111. GEA Biopharmaceutical Buffers Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GEA Product
Table 113. GEA Recent Development
Table 114. Global Biopharmaceutical Buffers Revenue Forecast by Region (2021-2026) (Million US$)
Table 115. Global Biopharmaceutical Buffers Production Forecast by Regions (2021-2026) (K MT)
Table 116. Global Biopharmaceutical Buffers Production Forecast by Type (2021-2026) (K MT)
Table 117. Global Biopharmaceutical Buffers Revenue Forecast by Type (2021-2026) (Million US$)
Table 118. North America Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 119. Europe Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 120. Asia Pacific Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 121. Latin America Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 122. Middle East and Africa Biopharmaceutical Buffers Consumption Forecast by Regions (2021-2026) (K MT)
Table 123. Biopharmaceutical Buffers Distributors List
Table 124. Biopharmaceutical Buffers Customers List
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Biopharmaceutical Buffers Product Picture
Figure 2. Global Biopharmaceutical Buffers Production Market Share by Type in 2020 & 2026
Figure 3. Sterile Buffer Product Picture
Figure 4. Non-sterile Buffer Product Picture
Figure 5. Global Biopharmaceutical Buffers Consumption Market Share by Application in 2020 & 2026
Figure 6. Recombinant Proteins
Figure 7. Monoclonal Antibodies
Figure 8. Antibiotics
Figure 9. Probiotics
Figure 10. Other
Figure 11. Biopharmaceutical Buffers Report Years Considered
Figure 12. Global Biopharmaceutical Buffers Revenue 2015-2026 (Million US$)
Figure 13. Global Biopharmaceutical Buffers Production Capacity 2015-2026 (K MT)
Figure 14. Global Biopharmaceutical Buffers Production 2015-2026 (K MT)
Figure 15. Global Biopharmaceutical Buffers Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Biopharmaceutical Buffers Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Biopharmaceutical Buffers Revenue in 2019
Figure 19. Global Biopharmaceutical Buffers Production Market Share by Region (2015-2020)
Figure 20. Biopharmaceutical Buffers Production Growth Rate in North America (2015-2020) (K MT)
Figure 21. Biopharmaceutical Buffers Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Biopharmaceutical Buffers Production Growth Rate in Europe (2015-2020) (K MT)
Figure 23. Biopharmaceutical Buffers Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Biopharmaceutical Buffers Production Growth Rate in China (2015-2020) (K MT)
Figure 25. Biopharmaceutical Buffers Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Biopharmaceutical Buffers Production Growth Rate in Japan (2015-2020) (K MT)
Figure 27. Biopharmaceutical Buffers Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Biopharmaceutical Buffers Consumption Market Share by Regions 2015-2020
Figure 29. North America Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 30. North America Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 31. North America Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 32. U.S. Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 33. Canada Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 34. Europe Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 35. Europe Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 36. Europe Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 37. Germany Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 38. France Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 39. U.K. Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 40. Italy Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 41. Russia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 42. Asia Pacific Biopharmaceutical Buffers Consumption and Growth Rate (K MT)
Figure 43. Asia Pacific Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Biopharmaceutical Buffers Consumption Market Share by Regions in 2019
Figure 45. China Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 46. Japan Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 48. India Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 49. Australia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 50. Taiwan Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 51. Indonesia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 52. Thailand Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 53. Malaysia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 54. Philippines Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 55. Vietnam Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 56. Latin America Biopharmaceutical Buffers Consumption and Growth Rate (K MT)
Figure 57. Latin America Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 58. Latin America Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 59. Mexico Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 60. Brazil Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 61. Argentina Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 62. Middle East and Africa Biopharmaceutical Buffers Consumption and Growth Rate (K MT)
Figure 63. Middle East and Africa Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 65. Turkey Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 66. Saudi Arabia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 67. U.A.E Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 68. Global Biopharmaceutical Buffers Production Market Share by Type (2015-2020)
Figure 69. Global Biopharmaceutical Buffers Production Market Share by Type in 2019
Figure 70. Global Biopharmaceutical Buffers Revenue Market Share by Type (2015-2020)
Figure 71. Global Biopharmaceutical Buffers Revenue Market Share by Type in 2019
Figure 72. Global Biopharmaceutical Buffers Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Biopharmaceutical Buffers Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Biopharmaceutical Buffers Market Share by Price Range (2015-2020)
Figure 75. Global Biopharmaceutical Buffers Consumption Market Share by Application (2015-2020)
Figure 76. Global Biopharmaceutical Buffers Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Biopharmaceutical Buffers Consumption Market Share Forecast by Application (2021-2026)
Figure 78. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Sartorius StedimBiotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Eppendorf Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Nova Biomedicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Becton, and Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GEA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Global Biopharmaceutical Buffers Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 90. Global Biopharmaceutical Buffers Revenue Market Share Forecast by Regions ((2021-2026))
Figure 91. Global Biopharmaceutical Buffers Production Forecast by Regions (2021-2026) (K MT)
Figure 92. North America Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 93. North America Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Europe Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 95. Europe Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 96. China Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 97. China Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Japan Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 99. Japan Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Global Biopharmaceutical Buffers Consumption Market Share Forecast by Region (2021-2026)
Figure 101. Biopharmaceutical Buffers Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
Figure 1. Biopharmaceutical Buffers Product Picture
Figure 2. Global Biopharmaceutical Buffers Production Market Share by Type in 2020 & 2026
Figure 3. Sterile Buffer Product Picture
Figure 4. Non-sterile Buffer Product Picture
Figure 5. Global Biopharmaceutical Buffers Consumption Market Share by Application in 2020 & 2026
Figure 6. Recombinant Proteins
Figure 7. Monoclonal Antibodies
Figure 8. Antibiotics
Figure 9. Probiotics
Figure 10. Other
Figure 11. Biopharmaceutical Buffers Report Years Considered
Figure 12. Global Biopharmaceutical Buffers Revenue 2015-2026 (Million US$)
Figure 13. Global Biopharmaceutical Buffers Production Capacity 2015-2026 (K MT)
Figure 14. Global Biopharmaceutical Buffers Production 2015-2026 (K MT)
Figure 15. Global Biopharmaceutical Buffers Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Biopharmaceutical Buffers Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Biopharmaceutical Buffers Revenue in 2019
Figure 19. Global Biopharmaceutical Buffers Production Market Share by Region (2015-2020)
Figure 20. Biopharmaceutical Buffers Production Growth Rate in North America (2015-2020) (K MT)
Figure 21. Biopharmaceutical Buffers Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Biopharmaceutical Buffers Production Growth Rate in Europe (2015-2020) (K MT)
Figure 23. Biopharmaceutical Buffers Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Biopharmaceutical Buffers Production Growth Rate in China (2015-2020) (K MT)
Figure 25. Biopharmaceutical Buffers Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Biopharmaceutical Buffers Production Growth Rate in Japan (2015-2020) (K MT)
Figure 27. Biopharmaceutical Buffers Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Biopharmaceutical Buffers Consumption Market Share by Regions 2015-2020
Figure 29. North America Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 30. North America Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 31. North America Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 32. U.S. Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 33. Canada Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 34. Europe Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 35. Europe Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 36. Europe Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 37. Germany Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 38. France Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 39. U.K. Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 40. Italy Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 41. Russia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 42. Asia Pacific Biopharmaceutical Buffers Consumption and Growth Rate (K MT)
Figure 43. Asia Pacific Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Biopharmaceutical Buffers Consumption Market Share by Regions in 2019
Figure 45. China Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 46. Japan Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 48. India Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 49. Australia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 50. Taiwan Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 51. Indonesia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 52. Thailand Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 53. Malaysia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 54. Philippines Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 55. Vietnam Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 56. Latin America Biopharmaceutical Buffers Consumption and Growth Rate (K MT)
Figure 57. Latin America Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 58. Latin America Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 59. Mexico Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 60. Brazil Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 61. Argentina Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 62. Middle East and Africa Biopharmaceutical Buffers Consumption and Growth Rate (K MT)
Figure 63. Middle East and Africa Biopharmaceutical Buffers Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Biopharmaceutical Buffers Consumption Market Share by Countries in 2019
Figure 65. Turkey Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 66. Saudi Arabia Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 67. U.A.E Biopharmaceutical Buffers Consumption and Growth Rate (2015-2020) (K MT)
Figure 68. Global Biopharmaceutical Buffers Production Market Share by Type (2015-2020)
Figure 69. Global Biopharmaceutical Buffers Production Market Share by Type in 2019
Figure 70. Global Biopharmaceutical Buffers Revenue Market Share by Type (2015-2020)
Figure 71. Global Biopharmaceutical Buffers Revenue Market Share by Type in 2019
Figure 72. Global Biopharmaceutical Buffers Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Biopharmaceutical Buffers Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Biopharmaceutical Buffers Market Share by Price Range (2015-2020)
Figure 75. Global Biopharmaceutical Buffers Consumption Market Share by Application (2015-2020)
Figure 76. Global Biopharmaceutical Buffers Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Biopharmaceutical Buffers Consumption Market Share Forecast by Application (2021-2026)
Figure 78. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Sartorius StedimBiotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Eppendorf Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Nova Biomedicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Becton, and Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GEA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Global Biopharmaceutical Buffers Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 90. Global Biopharmaceutical Buffers Revenue Market Share Forecast by Regions ((2021-2026))
Figure 91. Global Biopharmaceutical Buffers Production Forecast by Regions (2021-2026) (K MT)
Figure 92. North America Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 93. North America Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Europe Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 95. Europe Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 96. China Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 97. China Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Japan Biopharmaceutical Buffers Production Forecast (2021-2026) (K MT)
Figure 99. Japan Biopharmaceutical Buffers Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Global Biopharmaceutical Buffers Consumption Market Share Forecast by Region (2021-2026)
Figure 101. Biopharmaceutical Buffers Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
